Evidence map›Paper›PMID 26062521›Full record

ArticleJournal of endocrinological investigation2016

Artesunate protects pancreatic beta cells against cytokine-induced damage via SIRT1 inhibiting NF-κB activation.

L Yu, J F Chen, X Shuai, Y Xu, Y Ding, J Zhang, W Yang, X Liang, D Su, C Yan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Artemisinin and its derivatives: a potential therapeutic approach for oral lichen planus.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

L YuDepartment of Pathology, Nanjing Medical University, 140 Hanzhong Road, Nanjing, 210029, Jiangsu, China.
J F ChenDepartment of Endocrinology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China.
X ShuaiDepartment of Pathology, Nanjing Medical University, 140 Hanzhong Road, Nanjing, 210029, Jiangsu, China.
Y XuDepartment of Pathology, Nanjing Medical University, 140 Hanzhong Road, Nanjing, 210029, Jiangsu, China.
Y DingDepartment of Pathology, Nanjing Medical University, 140 Hanzhong Road, Nanjing, 210029, Jiangsu, China.
J ZhangDepartment of Laboratory Medicine, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, China.
W YangDepartment of Laboratory Medicine, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, China.
X LiangThe Center of Metabolic Disease Research, Nanjing Medical University, 140 Hanzhong Road, Nanjing, 210029, Jiangsu, China.
D SuDepartment of Pathology, Nanjing Medical University, 140 Hanzhong Road, Nanjing, 210029, Jiangsu, China. sudongming@njmu.edu.cn.
C YanDepartment of Endocrinology, Clinical Medical College of Yangzhou University, Yangzhou, 225001, Jiangsu, China. yancaifeng@126.com.
Nanjing Medical University · CNJiangsu Province Hospital · CNYangzhou University · CNZhangzhou Municipal Hospital of Fujian Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimArtesunate (ART) has been known as the most effective and safe reagents to treat malaria for many years. In this study, we explored whether ART could protect pancreatic beta-cell against cytokine-induced damage. MATERIALS AND

methodsThe production of nitrite (NO) was detected with the Griess Assay Kit. SIRT1 and inducible nitric oxide synthase (iNOS) expression were determined with Western blot. The transcriptional activity of NF-κB was evaluated by luciferase reporter assay. The expression of Sirt1 was silenced by RNA interference. Glucose-stimulated insulin secretion (GSIS) and potassium-stimulated insulin secretion (KSIS) assays were performed to measure the effect of ART on pancreatic beta-cells' function. The effect of ART on beta-cells apoptosis was evaluated by using Hochest/PI staining and TUNEL assay.

resultsART enhanced GSIS (KSIS) and reduced apoptosis of pancreatic beta-cells induced by IL-1β. Further study showed that ART inhibited IL-1β-induced increase of NF-κB activity, iNOS expression, and NO production. Moreover, ART up-regulated SIRT1 expression in INS-1 cells and islets exposed to IL-1β. Inhibition of SIRT1 expression could partially abolished the inhibitory effect of ART on NF-κB activity in IL-1β-treated beta-cells. More importantly, the protective effect of ART on cytokine-induced damage was reversed by silencing SIRT1 expression.

conclusionsART can elicit a protective effect on beta-cells exposed to IL-1β by stimulating SIRT1 expression, which resulted in the decrease of NF-κB activity, iNOS expression, and NO production. Hence, ART might be an effective drug for diabetes.

Indexed as

AnimalsApoptosisArtemisininsArtesunateCells, CulturedCytokinesCytoprotectionFeasibility StudiesInsulin-Secreting CellsMaleNF-kappa BRatsRats, Sprague-DawleySignal TransductionSirtuin 1ArtemisininsArtesunateCytokinesNF-kappa BSirt1 protein, ratSirtuin 1ArtesunateIL-1βNF-κBPancreatic beta-cellSIRT1

Identifiers

PMID26062521
OpenAlexW610015475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.